The iwCLL 2017 meeting
How is the landscape of Hodgkin lymphoma therapy changing?
What is the rationale for novel combination therapies?
Niels van de Donk
What is the focus of lymphoma research in 2017?
The 2016 International Workshop of the German CLL Study Group (GCLLSG)